Evidence map›Paper›PMID 33604408›Full record

ArticleOpen forum infectious diseases2021

Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study.

Jose R Castillo-Mancilla, Matthias Cavassini, Marie Paule Schneider, Hansjakob Furrer, Alexandra Calmy, Manuel Battegay, Giulia Scanferla, Enos Bernasconi, Huldrych F Günthard, Tracy R Glass and 1 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 2 countries.

Jose R Castillo-MancillaUniversity of Colorado-AMC, Aurora, Colorado, USA.
Matthias CavassiniInfectious Diseases Service, Lausanne University Hospital, Lausanne, Switzerland.ORCID https://orcid.org/0000-0003-0933-7833
Marie Paule SchneiderSchool of Pharmaceutical Sciences and Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
Hansjakob FurrerDepartment of Infectious Diseases, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.
Alexandra CalmyDivision of Infectious Diseases, HIV/AIDS Unit, Geneva University Hospitals, Geneva, Switzerland.
Manuel BattegayUniversity of Basel, Basel, Switzerland.
Giulia ScanferlaDivision of Infectious Diseases, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Enos BernasconiDivision of Infectious Diseases, Ospedale Regionale di Lugano, Lugano, Switzerland.
Huldrych F GünthardDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Tracy R GlassUniversity of Basel, Basel, Switzerland.
Swiss HIV Cohort Study
Swiss Tropical and Public Health Institute · CHUniversity of Basel · CHUniversity of Zurich · CHOspedale regionale di Lugano · CHUniversity of Bern · CHUniversity Hospital of Geneva · CHUniversity of Lausanne · CHKantonsspital St. Gallen · CHUniversity of Colorado Denver · USUniversity of Geneva · CH

Funding

New Pharmacologic Measures of ART Adherence and Exposure: Pathway to Clinical ImplementationR01AI145453 · NIAID · UNIVERSITY OF COLORADO DENVER · PI ANDERSON, PETER L. · 2019 to 2023
$3.7M
NIAID NIH HHS R01 AI145453Swiss National Science Foundation 177499
6 · The paper itself

Abstract

backgroundIncomplete antiretroviral therapy (ART) adherence, even if sufficient to maintain viral suppression, is associated with enhanced inflammation in persons with HIV (PWH). However, its clinical implications remain unknown.

methodsPWH enrolled in the Swiss HIV Cohort Study without a history of cardiovascular disease (CVD) who initiated ART between 2003 and 2018 and had viral suppression (<50 copies/mL) for ≥6 months were evaluated. The association between incomplete self-reported ART adherence (≥1 or ≥2 missed doses in the last month) and (1) any CVD event (myocardial infarction, revascularization, cerebral hemorrhage, stroke, and/or death due to CVD event) or (2) non-CVD-related death was evaluated using adjusted Cox proportional hazards models.

resultsA total of 6971 PWH (74% male) were included in the analysis (median age [interquartile range {IQR}], 39 [32-47] years). The median (IQR) follow-up was 8 (4-11) years, with 14 (8-23) adherence questionnaires collected per participant. In total, 205 (3%) participants experienced a CVD event, and 186 (3%) died a non-CVD-related death. In an adjusted competing risk model where missing data were imputed, missing ≥1 ART dose showed an increased, but not statistically significant, risk for CVD events (hazard ratio [HR], 1.23; 95% CI, 0.85-1.79;

conclusionsIncomplete ART adherence was significantly associated with an increased risk for non-CVD-related mortality in PWH with virologic suppression. This highlights the potential role of nonadherence to ART as a driver of non-AIDS clinical outcomes.

Indexed as

adherenceantiretroviral therapycardiovascular diseaseviral suppression

Identifiers

PMID33604408
PMCPMC7880264
OpenAlexW3124625218

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.